Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors.
diagnosis
thymic carcinoma
thymic epithelial tumor
thymoma
treatment
Journal
Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
16
02
2023
accepted:
23
02
2023
medline:
26
4
2023
pubmed:
17
3
2023
entrez:
16
3
2023
Statut:
ppublish
Résumé
Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended. Radiotherapy or chemotherapy may be used as postoperative adjuvant treatment. Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first- and second-line treatment regimens. Recently, targeted therapies and immune checkpoint inhibitors have shown promising outcomes in TETs. Based on the currently available clinical evidences and the opinions of the national experts, the Thymic Oncology Group of Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) established this Chinese expert consensus on the clinical diagnosis and treatment of TETs, covering the epidemiology, diagnosis, treatment, prognosis and follow-up of TETs.
Identifiants
pubmed: 36924056
doi: 10.1111/1759-7714.14847
pmc: PMC10125784
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1102-1117Informations de copyright
© 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Références
Cancer. 1994 May 15;73(10):2491-8
pubmed: 8174044
Ann Thorac Surg. 2012 May;93(5):1668-72; discussion 1672-3
pubmed: 22421590
BMC Med. 2022 May 10;20(1):154
pubmed: 35534877
Ann Cardiothorac Surg. 2019 Mar;8(2):174-193
pubmed: 31032201
Jpn J Clin Oncol. 2011 Aug;41(8):1013-6
pubmed: 21742653
J Cancer Res Clin Oncol. 2020 Sep;146(9):2267-2276
pubmed: 32514629
J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S323-6
pubmed: 20859127
Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):98-105
pubmed: 31987968
J BUON. 2021 Jul-Aug;26(4):1198-1207
pubmed: 34564969
J Thorac Oncol. 2014 Dec;9(12):1810-5
pubmed: 25393794
J Clin Oncol. 2019 Aug 20;37(24):2162-2170
pubmed: 29906252
Lung Cancer (Auckl). 2019 Apr 02;10:37-46
pubmed: 31037036
J Thorac Oncol. 2016 Oct;11(10):1785-92
pubmed: 27346413
Ann Surg Oncol. 2014 Jan;21(1):322-8
pubmed: 23982255
J Thorac Oncol. 2018 Nov;13(11):1762-1770
pubmed: 30138763
Interact Cardiovasc Thorac Surg. 2012 Aug;15(2):273-5
pubmed: 22552797
J Thorac Cardiovasc Surg. 2014 Jan;147(1):36-44, 46.e1
pubmed: 24139613
J Thorac Oncol. 2017 Jun;12(6):993-1000
pubmed: 28341225
J Thorac Oncol. 2009 Jul;4(7):911-9
pubmed: 19557895
J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S357-60
pubmed: 20859133
Lancet Oncol. 2014 Feb;15(2):191-200
pubmed: 24439931
Eur J Cancer. 2008 May;44(8):1078-82
pubmed: 18439818
Eur J Cancer. 2022 Oct;174:31-36
pubmed: 35970033
J Thorac Oncol. 2017 Apr;12(4):734-744
pubmed: 28126540
Jpn J Clin Oncol. 2020 Apr 7;50(4):434-439
pubmed: 32134448
Transl Lung Cancer Res. 2018 Apr;7(2):106-113
pubmed: 29876309
Ann Oncol. 2015 Feb;26(2):363-8
pubmed: 25403584
Lung Cancer. 2010 Feb;67(2):194-7
pubmed: 19409644
Pharmaceuticals (Basel). 2021 Apr 01;14(4):
pubmed: 33915954
Eur J Cancer. 2022 Oct;174:21-30
pubmed: 35970032
Ann Thorac Surg. 2003 Sep;76(3):878-84; discussion 884-5
pubmed: 12963221
J Thorac Dis. 2016 Apr;8(4):687-95
pubmed: 27114836
Onco Targets Ther. 2016 Oct 14;9:6337-6342
pubmed: 27789964
J Clin Oncol. 2018 Feb 1;36(4):342-349
pubmed: 29240542
Lancet Oncol. 2018 Mar;19(3):347-355
pubmed: 29395863
Radiat Oncol. 2013 Aug 13;8:199
pubmed: 23937886
J Thorac Dis. 2013 Apr;5(2):161-4
pubmed: 23585943
Thorac Surg Clin. 2011 Feb;21(1):107-14, viii
pubmed: 21070992
Cancer Cell. 2018 Feb 12;33(2):244-258.e10
pubmed: 29438696
J Thorac Oncol. 2020 Mar;15(3):448-456
pubmed: 31726106
Pediatr Blood Cancer. 2021 Jun;68 Suppl 4:e29042
pubmed: 33881200
Sci Rep. 2014 Dec 08;4:7336
pubmed: 25482724
Lancet Oncol. 2020 Jun;21(6):843-850
pubmed: 32502444
Zhonghua Zhong Liu Za Zhi. 2021 Apr 23;43(4):395-404
pubmed: 33902202
J Clin Oncol. 2011 May 20;29(15):2060-5
pubmed: 21502559
J Med Invest. 2008 Feb;55(1-2):17-28
pubmed: 18319541
Acta Oncol. 2018 Dec;57(12):1713-1720
pubmed: 30264630
Clin Lung Cancer. 2016 Sep;17(5):362-366
pubmed: 27372386
Thorac Cancer. 2023 Apr;14(12):1102-1117
pubmed: 36924056
Autoimmun Rev. 2016 Jan;15(1):82-92
pubmed: 26408958
Ann Oncol. 2015 Sep;26 Suppl 5:v40-55
pubmed: 26314779
Ann Thorac Surg. 2008 Feb;85(2):385-9
pubmed: 18222230
Nat Genet. 2014 Aug;46(8):844-9
pubmed: 24974848
Ann Thorac Surg. 2017 Sep;104(3):1047-1053
pubmed: 28619540
Eur J Cardiothorac Surg. 2019 Apr 1;55(4):601-609
pubmed: 30649256
Cancers (Basel). 2022 Jul 12;14(14):
pubmed: 35884448
J Thorac Cardiovasc Surg. 1996 Aug;112(2):376-84
pubmed: 8751506
J Thorac Oncol. 2022 Jun;17(6):827-837
pubmed: 35158083
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):775-81
pubmed: 19515503
Cancer Med. 2023 Mar;12(5):5649-5655
pubmed: 36394097
Cancers (Basel). 2022 Oct 08;14(19):
pubmed: 36230861
J Thorac Oncol. 2022 Feb;17(2):200-213
pubmed: 34695605
Zhongguo Fei Ai Za Zhi. 2016 Jul 20;19(7):414-7
pubmed: 27339717
Oncol Rep. 2008 Jun;19(6):1525-31
pubmed: 18497960
Lancet Oncol. 2015 Feb;16(2):177-86
pubmed: 25592632
Radiother Oncol. 2016 Mar;118(3):504-9
pubmed: 26895711
Ann Thorac Surg. 2017 May;103(5):1668-1675
pubmed: 28366466
J Thorac Oncol. 2021 Apr;16(4):677-685
pubmed: 33515812
J Clin Oncol. 1997 Sep;15(9):3093-9
pubmed: 9294472
Cancer. 2015 Apr 1;121(7):1008-16
pubmed: 25565590
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):427-433
pubmed: 28871993
Ann Thorac Surg. 2019 Feb;107(2):355-362
pubmed: 30316850
J Cancer Res Clin Oncol. 2015 Feb;141(2):323-31
pubmed: 25146529